A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7,12-dimethylbenz[tf]anthracene-induced rat mammary tumors

International Journal of Oncology

Volumn 14, Issue 2, 1999, Pages 259-263

  Sugamata, Noritaka ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Aromatasc inhibitor; DMBA induced rat mammary tumors; Insulin like growth factor I; Vorozole

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ENZYME INHIBITOR; SOMATOMEDIN C; TRIAZOLE DERIVATIVE; VOROZOLE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; ENZYME INHIBITORS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; TRIAZOLES;

EID: 0033074435     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sutherland RL, Rcddcl RR, Murphy LC and Taylor IW: Effects of anti-estrogens on cell cycle progression. In: Estrogen/Antiestrogen Action and Breast Cancer Therapy. Jordan VC (ed). The University of Wiconsin Press, Wisconsin, pp265-282, 1986.
2. Lippman ME, Huff KK, Jakesz R, Hecht T, Kasid A, Bates S and Dickson RB: Estrogens regulate production of specific growth factors in hormone-dependant human breast cancer. In: Estrogen/Anticstrogen Action and Breast Cancer Therapy. Jordan VC (ed). The University of Wisconsin Press, Wisconsin, pp237-248, 1986.
3. Sporn MB and Roberts AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
4. Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P and Kidwell WR: Presence of transforming growth factors in human breast cancer cells. Cancer Res 44: 4069-4077, 1984.
5. Bronzcrt DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB and Lippman ME: Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 84: 5763-5767,1987.
6. Vignon F, Capony F, Chambon M, Freiss G, Garcia M and Rochefort H: Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogcn regulated 52 kDa protein. Endocrinology 118: 1537-1545,1986.
7. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME and Dickson RB: Secretion of an insulin-like growth factorl-related protein by human breast cancer cells. Cancer Res 46: 4613-4619, 1986.
8. Krywicki RF and Yee D: The insulin-like growth factor family of ligands, receptor, and binding proteins. Breast Cancer Res Treat 22: 7-19, 1992.
9. Rinderknecht E and Humbel RE: The amino acid sequence of human insulin-like growth factor-I and its structural homology with proinsulin. J Biol Chem 253: 2769-2776, 1978.
10. Rinderknecht E and Humbel RE: Primary structure of human insulin-like growth factor-II. FEBS Lett 89: 283-286, 1978.
11. Baxter RC: The somatomedins: insulin-like growth factors. Adv Clin Chem 25:49-115, 1986.
12. De Leon DD, Bakker B, Wilson DM, Hintz RL and Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152: 398-405, 1988.
13. Stewart AJ, Johnson MD, May FEB and Westley BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265: 21172-21178, 1990.